Antimicrobial Agents and Chemotherapy · 2016 · 19 citations · 19 references
Veterinary MedicineInfectious DiseasesPharmaceutical AnalysisAntimicrobial PharmacologyAntimicrobial PharmacotherapyDiagnostic MicrobiologyMycobacterial DiagnosticsTuberculosis DiagnosisTuberculosis Diagnostic TestingDrug Resistance TestingImmunoassay MethodologyInterpretation Of Test ResultsLiquid Chromatography-mass SpectrometryLiquid Chromatography-mass Spectrometry AnalysisMultidrug-resistant OrganismsMultidrug-resistant PathogensMultidrug-resistant Tuberculosis Treatment
Kanamycin is one of the aminoglycosides used in the treatment of multidrug-resistant tuberculosis. Blood concentrations of kanamycin are predictive for the treatment efficacy and the occurrence of side effects, and dose adjustments can be needed to optimize therapy. However, an immunoassay method for the quantification of kanamycin is not commercially available. We modified the existing tobramycin immunoassay to analyze kanamycin. This modified method was tested in a concentration range of 0.3 to 80.0 mg/liter for inaccuracy and imprecision. In addition, the analytical results of the immunoassay method were compared to those obtained by a liquid chromatography-tandem mass spectrometry (LC-MS/MS) analytical method using Passing and Bablok regression. Within-day imprecision varied from 2.3 to 13.3%, and between-day imprecision ranged from 0.0 to 11.3%. The inaccuracy ranged from -5.2 to 7.6%. No significant cross-reactivity with other antimicrobials and antiviral agents was observed. The results of the modified immunoassay method were comparable with the LC-MS/MS analytical outcome. This new immunoassay method enables laboratories to perform therapeutic drug monitoring of kanamycin without the need for complex and expensive LC-MS/MS equipment.
19
H. Passing, W. Bablok · Clinical Chemistry and Laboratory Medicine (CCLM) · 1983 · 1.5K citations · Full text
CLSI C62-A: A New Standard for Clinical Mass Spectrometry
Kara L. Lynch · Clinical Chemistry · 2015 · 154 citations · Full text